These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 31835306

  • 21. Assessment of the mechanistic role of an Indian traditionally used ayurvedic herb Bacopa monnieri (L.)Wettst. for ameliorating oxidative stress in neuronal cells.
    Ghosh S, Kumar V, Mukherjee H, Saini S, Gupta S, Chauhan S, Kushwaha K, Lahiri D, Sircar D, Roy P.
    J Ethnopharmacol; 2024 Jun 28; 328():117899. PubMed ID: 38341111
    [Abstract] [Full Text] [Related]

  • 22. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
    Cardoso I, Goldsbury CS, Müller SA, Olivieri V, Wirtz S, Damas AM, Aebi U, Saraiva MJ.
    J Mol Biol; 2002 Apr 12; 317(5):683-95. PubMed ID: 11955017
    [Abstract] [Full Text] [Related]

  • 23. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
    Sato T, Ando Y, Susuki S, Mikami F, Ikemizu S, Nakamura M, Suhr O, Anraku M, Kai T, Suico MA, Shuto T, Mizuguchi M, Yamagata Y, Kai H.
    FEBS Lett; 2006 Jan 23; 580(2):491-6. PubMed ID: 16386248
    [Abstract] [Full Text] [Related]

  • 24. Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy.
    Hammarström P, Jiang X, Deechongkit S, Kelly JW.
    Biochemistry; 2001 Sep 25; 40(38):11453-9. PubMed ID: 11560493
    [Abstract] [Full Text] [Related]

  • 25. Plasminogen activation triggers transthyretin amyloidogenesis in vitro.
    Mangione PP, Verona G, Corazza A, Marcoux J, Canetti D, Giorgetti S, Raimondi S, Stoppini M, Esposito M, Relini A, Canale C, Valli M, Marchese L, Faravelli G, Obici L, Hawkins PN, Taylor GW, Gillmore JD, Pepys MB, Bellotti V.
    J Biol Chem; 2018 Sep 14; 293(37):14192-14199. PubMed ID: 30018138
    [Abstract] [Full Text] [Related]

  • 26. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression.
    Sekijima Y, Dendle MT, Wiseman RL, White JT, D'Haeze W, Kelly JW.
    Amyloid; 2006 Jun 14; 13(2):57-66. PubMed ID: 16911959
    [Abstract] [Full Text] [Related]

  • 27. Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid.
    Azevedo EP, Pereira HM, Garratt RC, Kelly JW, Foguel D, Palhano FL.
    Biochemistry; 2011 Dec 27; 50(51):11070-83. PubMed ID: 22091638
    [Abstract] [Full Text] [Related]

  • 28. Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants.
    Schwarzman AL, Tsiper M, Wente H, Wang A, Vitek MP, Vasiliev V, Goldgaber D.
    Amyloid; 2004 Mar 27; 11(1):1-9. PubMed ID: 15185492
    [Abstract] [Full Text] [Related]

  • 29. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis.
    Sörgjerd K, Ghafouri B, Jonsson BH, Kelly JW, Blond SY, Hammarström P.
    J Mol Biol; 2006 Feb 17; 356(2):469-82. PubMed ID: 16376939
    [Abstract] [Full Text] [Related]

  • 30. Transthyretin monomers: a new plasma biomarker for pre-symptomatic transthyretin-related amyloidosis.
    Costa-Rodrigues D, Leite JP, Saraiva MJ, Almeida MR, Gales L.
    Amyloid; 2024 Sep 17; 31(3):202-208. PubMed ID: 38946492
    [Abstract] [Full Text] [Related]

  • 31. Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism.
    Si JB, Kim B, Kim JH.
    Int J Mol Sci; 2021 Apr 23; 22(9):. PubMed ID: 33922648
    [Abstract] [Full Text] [Related]

  • 32. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
    Green NS, Palaninathan SK, Sacchettini JC, Kelly JW.
    J Am Chem Soc; 2003 Nov 05; 125(44):13404-14. PubMed ID: 14583036
    [Abstract] [Full Text] [Related]

  • 33. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Lai Z, Colón W, Kelly JW.
    Biochemistry; 1996 May 21; 35(20):6470-82. PubMed ID: 8639594
    [Abstract] [Full Text] [Related]

  • 34. Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion.
    Bourgault S, Solomon JP, Reixach N, Kelly JW.
    Biochemistry; 2011 Feb 15; 50(6):1001-15. PubMed ID: 21194234
    [Abstract] [Full Text] [Related]

  • 35. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.
    Green NS, Foss TR, Kelly JW.
    Proc Natl Acad Sci U S A; 2005 Oct 11; 102(41):14545-50. PubMed ID: 16195386
    [Abstract] [Full Text] [Related]

  • 36. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.
    Hurshman AR, White JT, Powers ET, Kelly JW.
    Biochemistry; 2004 Jun 15; 43(23):7365-81. PubMed ID: 15182180
    [Abstract] [Full Text] [Related]

  • 37. Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.
    Almeida MR, Macedo B, Cardoso I, Alves I, Valencia G, Arsequell G, Planas A, Saraiva MJ.
    Biochem J; 2004 Jul 15; 381(Pt 2):351-6. PubMed ID: 15080795
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.